Ardent Health Partners, LLC (ARDT) Financial Ratios
10 years of historical data (2016–2025) · Healthcare · Medical - Care Facilities
EV/EBITDA
↓
6.17
-6% vs avg
5yr avg: 6.53
30Y Low5.8·High7.2
P/FCF
↓
5.47
↓-52% vs avg
5yr avg: 11.30
30Y Low4.8·High17.8
P/B Ratio
↓
0.83
↓-26% vs avg
5yr avg: 1.12
30Y Low0.7·High1.5
ROE
↑
8.5%
↓+35% vs avg
5yr avg: 6.3%
30Y Low-19%·High21%
Debt/EBITDA
↑
4.71
↓-11% vs avg
5yr avg: 5.27
30Y Low1.5·High6.7
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
ARDT Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Ardent Health Partners, LLC trades at 10.3x earnings, roughly in line with its 5-year average of 10.0x, sitting at the 50th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a discount of 54%. On a free-cash-flow basis, the stock trades at 5.5x P/FCF, 52% below the 5-year average of 11.3x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.4B | $1.2B | $2.3B | — | — | — | — | — |
| Enterprise Value | $3.0B | $2.8B | $4.0B | — | — | — | — | — |
| P/E Ratio → | 10.29 | 9.20 | 10.81 | — | — | — | — | — |
| P/S Ratio | 0.22 | 0.20 | 0.38 | — | — | — | — | — |
| P/B Ratio | 0.83 | 0.74 | 1.49 | — | — | — | — | — |
| P/FCF | 5.47 | 4.83 | 17.78 | — | — | — | — | — |
| P/OCF | 3.00 | 2.65 | 7.20 | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
ARDT EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Ardent Health Partners, LLC's enterprise value stands at 6.2x EBITDA, 6% below its 5-year average of 6.5x. The Healthcare sector median is 14.4x, placing the stock at a 57% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.44 | 0.67 | — | — | — | — | — |
| EV / EBITDA | 6.17 | 5.83 | 7.23 | — | — | — | — | — |
| EV / EBIT | 9.12 | 8.61 | 9.31 | — | — | — | — | — |
| EV / FCF | — | 10.84 | 31.31 | — | — | — | — | — |
ARDT Profitability
Margins and return-on-capital ratios measuring operating efficiency
Ardent Health Partners, LLC earns an operating margin of 5.1%. ROE of 8.5% is modest. ROIC of 7.5% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 97.5% | 97.5% | 82.7% | 97.4% | 81.4% | 100.0% | 100.0% | 100.0% |
| Operating Margin | 5.1% | 5.1% | 6.8% | 4.2% | 4.2% | 3.6% | 4.1% | 4.0% |
| Net Profit Margin | 2.1% | 2.1% | 3.5% | 0.9% | 3.7% | -3.4% | -1.2% | 0.7% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| ROE | 8.5% | 8.5% | 16.2% | 4.7% | 21.4% | -19.4% | -6.2% | 3.7% |
| ROA | 2.7% | 2.7% | 4.2% | 1.0% | 5.0% | -5.6% | -2.1% | 1.3% |
| ROIC | 7.5% | 7.5% | 9.7% | 5.7% | 6.6% | 6.3% | 8.4% | 11.7% |
| ROCE | 7.9% | 7.9% | 10.0% | 5.6% | 7.0% | 7.5% | 9.3% | 11.2% |
ARDT Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Ardent Health Partners, LLC carries a Debt/EBITDA ratio of 4.7x, which is highly leveraged (43% above the sector average of 3.3x). Net debt stands at $1.6B ($2.3B total debt minus $710M cash). Interest coverage of 5.9x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.34 | 1.34 | 1.50 | 2.21 | 2.27 | 1.77 | 1.25 | 0.61 |
| Debt / EBITDA | 4.71 | 4.71 | 4.13 | 6.47 | 6.72 | 4.30 | 4.12 | 1.54 |
| Net Debt / Equity | — | 0.92 | 1.13 | 1.81 | 1.84 | 1.69 | 1.16 | 0.37 |
| Net Debt / EBITDA | 3.23 | 3.23 | 3.13 | 5.29 | 5.44 | 4.10 | 3.81 | 0.95 |
| Debt / FCF | — | 6.01 | 13.53 | 23.24 | — | — | — | 40.82 |
| Interest Coverage | 5.90 | 5.90 | 6.54 | 3.20 | 4.80 | 0.94 | 1.72 | 2.65 |
ARDT Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.97x means Ardent Health Partners, LLC can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 1.63x to 1.97x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.97 | 1.97 | 1.94 | 1.63 | 1.74 | 1.38 | 1.45 | 1.44 |
| Quick Ratio | 1.85 | 1.85 | 1.82 | 1.52 | 1.61 | 1.24 | 1.29 | 1.29 |
| Cash Ratio | 0.68 | 0.68 | 0.59 | 0.44 | 0.56 | 0.10 | 0.14 | 0.28 |
| Asset Turnover | — | 1.20 | 1.20 | 1.06 | 1.06 | 1.52 | 1.26 | 1.94 |
| Inventory Turnover | 1.31 | 1.31 | 8.98 | 1.34 | 8.91 | — | — | — |
| Days Sales Outstanding | — | 39.60 | 45.46 | 53.02 | 43.54 | 46.40 | 55.18 | 45.26 |
ARDT Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Ardent Health Partners, LLC does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 9.7% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | 92.5% | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 9.7% | 10.9% | 9.3% | — | — | — | — | — |
| FCF Yield | 18.3% | 20.7% | 5.6% | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | — | — | — | — | — |
| Shares Outstanding | — | $141M | $133M | $143M | $143M | $141M | $141M | $141M |
Peer Comparison
Compare ARDT with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 ARDTYou | $1B | 10.3 | 6.2 | 5.5 | 97.5% | 5.1% | 8.5% | 7.5% | 4.7 |
 HCA | $96B | 15.1 | 9.4 | 12.5 | 41.5% | 15.8% | — | 19.9% | 3.2 |
 THC | $17B | 12.5 | 6.3 | 6.7 | 82.3% | 16.1% | 16.1% | 13.2% | 3.1 |
 CYH | $408M | 0.8 | — | 2.0 | 8.7% | -79.4% | — | -70.1% | — |
 UHS | $11B | 7.4 | 6.1 | 12.6 | 90.4% | 11.5% | 21.0% | 12.3% | 2.1 |
 ENSG | $10B | 29.8 | 25.7 | 27.5 | 13.7% | 8.6% | 16.9% | 7.0% | 7.7 |
 SEM | $2B | 13.9 | 12.0 | 5.3 | 11.5% | 6.1% | 7.3% | 4.8% | 7.8 |
 ACHC | $2B | -2.0 | 8.3 | — | 17.6% | 11.7% | -41.4% | 5.9% | 4.6 |
 SGRY | $2B | -23.5 | 10.0 | 9.6 | 23.1% | 11.8% | -2.2% | 4.1% | 7.1 |
 USPH | $897M | 41.5 | 12.5 | 14.7 | 20.1% | 10.3% | 2.0% | 5.6% | 4.1 |
 MCK | $92B | 29.2 | 18.7 | 17.6 | 3.5% | 1.2% | — | 540.6% | 1.5 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
See ARDT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ARDT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ARDT vs HCA
Side-by-side business, growth, and profitability comparison vs HCA Healthcare, Inc..
Start ComparisonARDT — Frequently Asked Questions
Quick answers to the most common questions about buying ARDT stock.
What is Ardent Health Partners, LLC's P/E ratio?
Ardent Health Partners, LLC's current P/E ratio is 10.3x. The historical average is 10.0x. This places it at the 50th percentile of its historical range.
What is Ardent Health Partners, LLC's EV/EBITDA?
Ardent Health Partners, LLC's current EV/EBITDA is 6.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 6.5x.
What is Ardent Health Partners, LLC's ROE?
Ardent Health Partners, LLC's return on equity (ROE) is 8.5%. The historical average is 4.1%.
Is ARDT stock overvalued?
Based on historical data, Ardent Health Partners, LLC is trading at a P/E of 10.3x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Ardent Health Partners, LLC's profit margins?
Ardent Health Partners, LLC has 97.5% gross margin and 5.1% operating margin.
How much debt does Ardent Health Partners, LLC have?
Ardent Health Partners, LLC's Debt/EBITDA ratio is 4.7x, indicating high leverage. A ratio above 4x may signal elevated financial risk.